College of Stomatology, Ningxia Medical University, Yinchuan 750004, People's Republic of China. General Hospital of Ningxia Medical University, Yinchuan 750004, People's Republic of China.
Biomed Mater. 2020 Apr 28;15(3):035021. doi: 10.1088/1748-605X/ab7979.
In this study, basic fibroblast growth factor (bFGF) was loaded into a poly(lactic-co-glycolic acid) (PLGA)/wool keratin composite membrane by emulsion electrospinning to prepare a composite membrane with a core-shell structure for guided tissue regeneration (GTR). The physicochemical properties, drug release performance in vitro and cytotoxicity of the composite membrane were evaluated to select the optimum concentration of bFGF. The fibers in the six groups of composite membranes were uniform in thickness, had a smooth surface, and did not exhibit a string bead structure. In addition, the fibers in the six groups of composite membranes had a stable core-shell structure, in which the core layer of the fibers was wrapped around bFGF and the shell layer of the fibers comprised the PLGA/wool keratin oil-phase component. Compared with the PLGA/wool keratin composite membrane prepared by traditional electrospinning, the composite membranes prepared by emulsion electrospinning had a higher water absorption rate and superior hydrophilicity. The bFGF encapsulation rate of the 10 μg bFGF composite membrane was the highest (97.3% ± 11.3%). Stable and sustained release of bFGF from the five groups of bFGF-loaded PLGA/wool keratin composite membranes can be maintained over 28 d. The five groups of PLGA/wool keratin composite membranes loaded with bFGF could promote the adhesion, proliferation and osteogenic differentiation of human periodontal ligament fibroblasts (hPLDFs) to varying degrees. Among the five groups, the cell morphology, proliferation ability and osteogenic differentiation ability of the 10 μg bFGF composite membrane group were the best. This study will serve as a foundation for further research on bFGF-loaded composite membranes for GTR applications.
在这项研究中,碱性成纤维细胞生长因子(bFGF)被载入聚乳酸-共-羟基乙酸(PLGA)/羊毛角蛋白复合膜中,通过乳液静电纺丝制备了一种具有核壳结构的复合膜,用于引导组织再生(GTR)。评估了复合膜的物理化学性质、体外药物释放性能和细胞毒性,以选择 bFGF 的最佳浓度。六组复合膜的纤维厚度均匀,表面光滑,没有串珠结构。此外,六组复合膜的纤维均具有稳定的核壳结构,纤维的核层包裹 bFGF,纤维的壳层由 PLGA/羊毛角蛋白油相组成。与传统静电纺丝制备的 PLGA/羊毛角蛋白复合膜相比,乳液静电纺丝制备的复合膜具有更高的吸水率和更好的亲水性。10 μg bFGF 复合膜的 bFGF 包封率最高(97.3%±11.3%)。五组载 bFGF 的 PLGA/羊毛角蛋白复合膜中 bFGF 的释放稳定且可持续 28 天以上。五组载 bFGF 的 PLGA/羊毛角蛋白复合膜能在一定程度上促进人牙周膜成纤维细胞(hPLDFs)的黏附、增殖和成骨分化。在这五组中,10 μg bFGF 复合膜组的细胞形态、增殖能力和成骨分化能力最好。本研究将为进一步研究用于 GTR 的载 bFGF 复合膜奠定基础。